| Breakdown | TTM | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 181.16M | 161.97M | 149.96M | 142.08M | 125.60M | 103.20M |
| Gross Profit | 123.26M | 64.36M | 56.95M | 130.47M | 48.74M | 40.49M |
| EBITDA | 23.99M | 28.58M | 31.72M | 26.80M | 14.18M | 15.09M |
| Net Income | 1.18M | 7.58M | 9.85M | 7.94M | -2.53M | 3.40M |
Balance Sheet | ||||||
| Total Assets | 298.08M | 278.61M | 219.10M | 212.17M | 206.28M | 194.30M |
| Cash, Cash Equivalents and Short-Term Investments | 8.50M | 5.85M | 5.45M | 4.04M | 4.10M | 4.78M |
| Total Debt | 138.85M | 124.95M | 81.19M | 78.18M | 79.68M | 68.56M |
| Total Liabilities | 196.28M | 174.08M | 118.84M | 119.36M | 120.62M | 111.61M |
| Stockholders Equity | 101.81M | 104.53M | 100.26M | 92.81M | 85.66M | 82.69M |
Cash Flow | ||||||
| Free Cash Flow | 15.93M | 13.50M | 14.63M | 14.41M | 7.52M | 2.52M |
| Operating Cash Flow | 25.25M | 25.25M | 22.83M | 16.33M | 10.11M | 7.08M |
| Investing Cash Flow | -36.55M | -38.09M | -14.33M | -7.85M | -10.33M | -6.65M |
| Financing Cash Flow | 18.90M | 13.32M | -7.09M | -8.67M | 1.52M | -10.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £146.69M | 9.55 | 52.26% | 5.98% | 16.29% | 22.80% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £147.60M | -138.94 | 1.15% | 2.75% | 8.01% | -23.02% | |
60 Neutral | £284.31M | -3.42 | -12.22% | 15.28% | -3.91% | -310.36% | |
54 Neutral | £330.14M | 275.23 | 0.58% | 2.31% | 6.90% | 145.00% | |
41 Neutral | £329.87M | -2.81 | -142.88% | ― | -4.87% | ― |